Charles River Laboratories International (CRL) FY2012 results: revenue $1.1 billion, down 1.1% on the year
Charles River Laboratories International, Inc. (CRL) reported revenue of $1.1 billion for fiscal 2012, the year ended 29 December 2012, down 1.1% on the year before. Net income was $97 million, down 11.2%, and diluted earnings per share $2.01. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2015.
Revenue
$1.1 billion
-1.1% on the year
FY2008FY2012
Operating margin
14.7%
15.3% a year earlier
FY2008FY2012
Net income
$97 million
-11.2% on the year
FY2008FY2012
Diluted EPS
$2.01
-6.1% on the year
FY2008FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
1,130
1,143
1,133
-1.1%
Cost of revenue
737
740
749
-0.4%
Gross profit
392
402
385
-2.5%
Gross margin
34.7%
35.2%
33.9%
Selling, general and administrative
208
199
232
+4.8%
Operating income
166
174
-299
-4.9%
Operating margin
14.7%
15.3%
-26.3%
Interest expense
33.3
42.6
35.3
-21.7%
Pre-tax income
130
133
-334
-2.2%
Income tax
27.6
17.1
0.0
+61.2%
Effective tax rate
21.3%
12.9%
n/a
Net income
97.3
110
-337
-11.2%
Net margin
8.6%
9.6%
-29.7%
Diluted EPS
$2.01
$2.14
-$5.38
-6.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
n/a
205
169
Capital expenditure
47.5
49.1
42.9
-3.3%
Free cash flow
n/a
156
126
Free cash flow margin
n/a
13.7%
11.1%
Depreciation and amortisation
81.3
85.2
93.6
-4.6%
Share-based compensation
21.9
21.7
25.5
+0.7%
Buybacks
64.2
284
357
-77.4%
Diluted shares, weighted
48m
51m
63m
-5.7%
Shares outstanding at period end
49m
49m
56m
0.0%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
601
526
687
+14.3%
Non-controlling interest
2.4
1.8
1.3
+34.6%
Redeemable equity
0.0
n/a
n/a
Debt
666
718
701
-7.2%
Other liabilities
317
313
344
+1.2%
Total liabilities and equity
1,586
1,558
1,733
+1.8%
Fixed assets
717
738
753
-2.8%
Goodwill
209
198
198
+5.6%
Intangible assets
84.9
93.4
121
-9.1%
Investments
6.8
16.4
21.2
-58.7%
Cash and equivalents
110
68.9
179
+59.2%
Receivables
203
185
193
+9.8%
Inventory
88.5
93.0
100
-4.8%
Other assets
168
166
167
+1.0%
Total assets
1,586
1,558
1,733
+1.8%
10-K for the year ended 29 December 2012, filed 17 February 2015: the filing.